Correlation Between Coya Therapeutics, and Eliem Therapeutics
Can any of the company-specific risk be diversified away by investing in both Coya Therapeutics, and Eliem Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Coya Therapeutics, and Eliem Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Coya Therapeutics, Common and Eliem Therapeutics, you can compare the effects of market volatilities on Coya Therapeutics, and Eliem Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Coya Therapeutics, with a short position of Eliem Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Coya Therapeutics, and Eliem Therapeutics.
Diversification Opportunities for Coya Therapeutics, and Eliem Therapeutics
-0.4 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Coya and Eliem is -0.4. Overlapping area represents the amount of risk that can be diversified away by holding Coya Therapeutics, Common and Eliem Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eliem Therapeutics and Coya Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Coya Therapeutics, Common are associated (or correlated) with Eliem Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eliem Therapeutics has no effect on the direction of Coya Therapeutics, i.e., Coya Therapeutics, and Eliem Therapeutics go up and down completely randomly.
Pair Corralation between Coya Therapeutics, and Eliem Therapeutics
Given the investment horizon of 90 days Coya Therapeutics, Common is expected to under-perform the Eliem Therapeutics. In addition to that, Coya Therapeutics, is 1.46 times more volatile than Eliem Therapeutics. It trades about -0.25 of its total potential returns per unit of risk. Eliem Therapeutics is currently generating about -0.29 per unit of volatility. If you would invest 411.00 in Eliem Therapeutics on August 29, 2024 and sell it today you would lose (111.00) from holding Eliem Therapeutics or give up 27.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 90.91% |
| Values | Daily Returns |
Coya Therapeutics, Common vs. Eliem Therapeutics
Performance |
| Timeline |
| Coya Therapeutics, Common |
| Eliem Therapeutics |
Coya Therapeutics, and Eliem Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Coya Therapeutics, and Eliem Therapeutics
The main advantage of trading using opposite Coya Therapeutics, and Eliem Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Coya Therapeutics, position performs unexpectedly, Eliem Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eliem Therapeutics will offset losses from the drop in Eliem Therapeutics' long position.| Coya Therapeutics, vs. Cue Biopharma | Coya Therapeutics, vs. Lantern Pharma | Coya Therapeutics, vs. Fennec Pharmaceuticals | Coya Therapeutics, vs. Eliem Therapeutics |
| Eliem Therapeutics vs. Pmv Pharmaceuticals | Eliem Therapeutics vs. MediciNova | Eliem Therapeutics vs. Pharvaris BV | Eliem Therapeutics vs. PepGen |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |